thenewsfacts.com
  • Home
  • Latest News
  • Trending News
  • Technology
  • entertainment
  • Sports
  • Business
thenewsfacts.comthenewsfacts.com
Search
  • Home
  • Latest News
  • Trending News
  • Technology
  • entertainment
  • Sports
  • Business
Follow US
© thenewsfacts : All Rights Reserved.

COVID-19

Covaxin BHU Study
COVID VaccinesLatest News

Covaxin BHU Study: BB Points Flaws in Data Points, Backs Strong Safety Track Record

By NewsFacts Bureau

JN.1, A New Subvariant of COVID-19 in Kerala: Health Ministry Vigilant

By SK Panicker

India’s Covid-19 Cases Continue to Decline with 9,355 New Infections

By TheNewsFacts

COVAXIN production to be demand-driven, says Bharat Biotech

By TheNewsFacts
AM Green Uniper

Europe Bound: AM Green’s 500,000 TPA Renewable Ammonia Deal with Uniper

By NewsFacts Bureau
January 12, 2026
Indian Startups

Indian Startups Log $77M as New Year Begins Quietly

By NewsFacts Bureau
January 10, 2026
Dhurandhar

Unstoppable Dhurandhar, ₹800 Cr and Counting

By NewsFacts Bureau
January 7, 2026
Spirit Teaser

Spirit teaser: Prabhas, Triptii Dimri send fans into a frenzy

By NewsFacts Bureau
January 1, 2026

Latest Articles

Scientists Discover a Highly Mutant New COVID Variant; WHO to Hold Crisis Meet

Scientists Discover a Highly Mutant New COVID Variant; WHO to Hold Crisis Meet

By TheNewsFacts
COVAXIN effective even against High Risk Delta Variants - Ne AIIMS Study

COVAXIN effective even against High Risk Delta Variants – AIIMS New Study

By TheNewsFacts
COVAXIN Highly Effective Against Transmissible Delta Variant - The Lancet

COVAXIN Highly Effective Against Transmissible Delta Variant – The Lancet

By TheNewsFacts
COVAXIN Protects You From Multi- Covid-19 Variants - New NII study

COVAXIN Protects You From Multi- Covid-19 Variants – New NII study

By TheNewsFacts
covaxin

COVAXIN is a Triumph Over COVID-19 Pandemic

By TheNewsFacts
6 Highlights Of COVAXIN The Lancet Peer-Review

6 Key Findings of COVAXIN The Lancet Peer-Review

By TheNewsFacts
India's COVAXIN Gets WHO EUL Approval -Bharat Celebrates

India’s COVAXIN Gets WHO Approval -Bharat Celebrates

By TheNewsFacts
CDSCO Extends India's COVAXIN Shelf Life to 12 Months Now

CDSCO Extends India’s COVAXIN Shelf Life to 12 Months Now

By TheNewsFacts
1 2 … 7 8 9 10 11 … 24 25
thenewsfacts thenewsfacts

About US


TheNewsFacts: Brings you the interesting facts, news facts and updates from India an the world across politics, tech, entertainment, business, tending, and more. We deliver what you love to read.
Top Categories
  • Latest News
  • Trending News
  • Paris Olympics 2024
  • Sports
  • Entertainment
  • Business
  • Technology
Usefull Links
  • About The News Facts
  • Latest News
  • Privacy Policy
  • Editorial Policy
  • Disclaimer
  • Contact Us
Follow us
Facebook Twitter Instagram

© thenewsfacts. All Rights Reserved.

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?